Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel after CTO recanalization with Absorb scaffold
2013-002675-17Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Chronic coronary occlusion (CTO) and coronary arteriosclerosis comparing Brilique arm with Plavix arm (2 arms). Primary endpoint: Change in coronary blood flow under adenosine. Started May 2014; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
Chronic coronary occlusion (CTO)coronary arteriosclerosis
Beyond the preview
Go deeper on 2013-002675-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002675-17.